SandboxAQ has announced a partnership with Anthropic to embed its scientific AI models directly into Claude, aiming to make drug discovery tools accessible to researchers without requiring specialized computing expertise or backgrounds. The company believes the main obstacle in pharmaceutical research isn't the quality of AI models themselves, but rather how difficult they are to use. Drug discovery traditionally costs billions of dollars and takes up to a decade per viable molecule, with most candidates failing before reaching patients.
The company emerged approximately five years ago as a spinout from Alphabet, with Eric Schmidt, Google's former CEO, serving as chairman. SandboxAQ has secured over $950 million in funding from investors and developed multiple business divisions, including cybersecurity operations. Its core innovation lies in proprietary Large Quantitative Models (LQMs), which the company describes as "physics-grounded"—meaning they operate based on physical laws rather than text pattern recognition. These models can execute quantum chemistry calculations and simulate molecular dynamics and microkinetics, allowing researchers to predict how drug candidates will behave before expensive laboratory experiments.
Nadia Harhen, SandboxAQ's general manager of AI simulation, highlighted the significance of this integration: "For the first time, we have a frontier [quantitative] model on a frontier LLM that someone can access in natural language." Previously, accessing these models required users to provide their own digital infrastructure and technical expertise. The company positions its technology within the "quantitative economy," a market it values at over $50 trillion spanning biopharma, financial services, energy, and advanced materials. While competitors like Chai Discovery and Isomorphic Labs concentrate on improving model accuracy for scientific applications, SandboxAQ is prioritizing accessibility—putting sophisticated drug discovery capabilities behind a conversational interface that any qualified researcher can operate.